← board
DERM
distress 2/10 · well-funded / low risk$7.01-2%today-24% from 52w high
journeymedicalcorp.com58 employeesFounded 2014Scottsdale, AZDrug Manufacturers - Specialty & Generic
Revenue
$16M
Liquidity
$27M
Runway
4.1 yrs
Shares 1y
—
Price & events
-24.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.5%
1D
-1.4%
1W
+4.6%
1M
+36.6%
3M
-19.2%
6M
-5.1%
1Y
+29.6%
2Y
—
5Y
-29.2%
All
Overview
- Volume
- 22.06K
- 52 Week Range
- $4.39 – $9.26
- Float Shares
- 14.90M
- Short %
- 19.73%
- % Held by Insiders
- 32.77%
- % Held by Institutions
- 59.25%
- RVOL
- 0.08x
- Beta
- 1.07
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 3
- 2026-08-11Estimated 45%earningsEarningsEarnings releaseyahoo
- 2026-04-21partnershipEmrosi · Secured contract with third major GPO, expanding payer access from approximately 100 million to over 150 million commercial lives as of April 1, 2026.SEC 8-K
- 2025-07-14partnershipEmrosi · Expanded payer coverage to 65% of commercial lives from 29% in May 2025SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $14 (+93% upside) · 4 analysts
- 2026-03-26HC Wainwright & Co.Buy
- 2025-08-25HC Wainwright & Co.Buy
- 2025-08-13Lake StreetBuy
- 2025-07-30B. Riley SecuritiesBuy
Competitors
- none identified
Recent news
- 2026-07-22WASATCH ADVISORS LP Acquires Additional Shares in Journey Medica - GuruFocus
- 2026-07-15Journey Medical (DERM) gains 13.3% shareholder in Wasatch Advisors - Stock Titan
- 2026-07-10Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
- 2026-07-02Journey Medical (DERM) grants 50,000 restricted stock units to director - Stock Titan
- 2026-07-02Journey Medical (DERM) director awarded 50,000 RSUs in long-term stock plan grant - Stock Titan
- 2026-07-02Journey Medical (DERM) grants director 50,000 restricted stock units - Stock Titan
- 2026-06-29Journey Medical (DERM) director receives 10,000 RSU equity award, now holds 118,618 shares - Stock Titan
- 2026-06-26Journey Medical Corporation (DERM) Files Form 8-K with SEC – Key Company Details and Filing Information (June 24, 2026) – Minichart - Minichart
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.